John Haley
Analyst · Raymond James
Thank you, Aida, and good morning, everyone. Today, we’ll review our results for the second quarter of 2017 and discuss outlook for the remainder of 2017. Reported revenues for the quarter were $1.95 billion, that’s flat as compared to the prior year second quarter, up 2% on both a constant currency and organic basis. Adjusted revenues for the quarter declined 1% as compared to the prior year second quarter, but were up 1% on both the constant currency and organic basis. Reported and adjusted revenues include $43 million of negative currency movement. As a reminder, adjusted revenues for the second quarter of 2016 include $26 million of revenue, which was not recognized as GAAP revenue due to purchase accounting rules. The second quarter of 2016 was the last quarter for such adjustments. As a reminder, the $41 million settlement we received from JLT for the Fine Arts and Jewelry business was included in the second quarter 2016 revenues. In the second quarter of 2017, we received $6 million in settlement payments, primarily related to the loss of a team in South Florida. As we mentioned in the first quarter, revenues were positively impacted due to the timing of the Easter holiday, timing of renewals and work that derived from regulatory changes. Therefore, in reviewing the results, our six month results more accurately reflect the business momentum. For the first half of 2017, reported total revenue growth was 2% as compared to the same period in the prior year, and up 4% on both the constant currency and organic basis. Adjusted revenues for the first half of 2017 increased 1% as compared to the same period in the prior year, up 3% on both a constant currency and organic basis. Adjusted revenues for the first half of a 2016 include $58 million of revenue not recognized due to purchase accounting rules. Reported and adjusted revenues include $93 million of negative currency movement for the first half of the year. Net income for the quarter was $41 million as compared to the prior year's second quarter net income of $76 million. Adjusted EBITDA for the quarter was $387 million or 19.8% of revenues as compared to the prior year second quarter adjusted EBITDA of $406 million or 20.6% of adjusted revenues. Net income for the first half of 2017 was $393 million as compared to the same period and the prior year net income of $321 million. Adjusted EBITDA for the first half of 2017 was $1.10 or -- sorry, $1.1 billion or 25.6% of revenues as compared to the first half in the prior year adjusted EBITDA of $1.08 billion or 25.4% of adjusted revenues. As a reminder, the first quarter is seasonally strong and margin is seasonally lower in subsequent quarters. As expected, the second quarter margin came in softer than the first. In addition to the seasonality, the 2016 JLT settlement negatively impacted margin comparison by 2 percentage points. While the second quarter margin enhancement may be masked somewhat by the JLT settlement, we're very pleased with our efforts this quarter with expense management. For the quarter, diluted earnings per share were $0.24 and adjusted diluted earnings per share were $1.45. Currency fluctuations net of hedging had a negative impact of $0.06 on adjusted diluted EPS. Before moving on to the segment results, I'd like to provide an update on 3 areas of integration: revenue synergies, cost synergies and tax savings. I'll start with revenue synergies. Our merger objective identified 3 specific areas of revenue synergies: global health solutions, the U.S. REIT market exchange and large market P&C. We've already achieved approximately 46% of our 3-year global health solutions synergies sales goal, and the sales pipeline continues to be robust. Integrated global management of employee health benefits brings a clear value-add to our clients, and that is showing through in the results of our sales effort. It's still a bit early to make any conclusions on the mid-market exchange progress as the sales season continues into November. However, we have a strong sales pipeline as we see the interest in the mid-market maintaining the momentum we experienced last year. Finally, we've won 18 large company P&C broker assignments in the first half of this year. We've been refining our marketing strategy into a more targeted approach and are pleased with the number of wins we've had to date. Our win rates in the large market are somewhat higher than the mid-market, but there are fewer proposals in the large market. While the initial wins are generating modest revenues, we feel positive about the development of key relationships, which we hope to expand on in an effort to help us achieve our long-term growth objectives. As we mentioned previously, we surpassed our original goal of a 25% adjusted tax rate a full year ahead of schedule. Our 2017 guidance anticipated achieving $30 million in merger-related savings. We continue to feel confident in achieving our 2017 savings objective and the overall savings goal of $125 million as we exit 2018. Now turning to the Operational Improvement Program or OIP. We continue to anticipate generating an additional $95 million of savings as we exit 2017. Most of the benefits associated with the saving program will impact 2018, and many of these programs are weighted to the second half of 2017. The program remains on track to be completed at the end of 2017. We continue to see progress in driving OIP and merger-related savings to the bottom line, but cost in margin management will remain a priority. Now let's look at each of the segments in more detail. As a reminder, beginning in 2017, we made certain changes that affected our segment results. These changes were detailed in the Form 8-K we filed with the SEC on April 7, 2017. For the quarter, total segment constant currency commissions and fees grew 2%. Constant currency commissions and fees for Human Capital & Benefits increased 1%; Corporate Risk and Broking increased 1%; Investment, Risk & Reinsurance increased 3%; and Exchange Solutions increased 15%. All of the revenue results discussed in the segment detail and guidance reflect commission and fees constant currency, unless specifically stated otherwise. So turning to Human Capital & Benefits or HCB. Commissions and fees constant currency growth was 1% and organic growth was flat. For the first half of the year, on an organic basis, HCB commissions and fees growth was 3%. As I mentioned earlier, due to the timing of Easter and early renewals, comparing the first half results year-over-year is a better indicator of business momentum than quarter-over-quarter. Retirement commissions and fees were down by 2%. Great Britain experienced strong growth this quarter, however, was offset by declines in Western Europe due to the timing of Easter and in North America, as a result of lower demand for both lump-sum projects. The growth in Great Britain was a result of increased actuarial project demand, primarily work relating to legislative changes. Talent and Rewards commissions and fees were down 1%, primarily due to a decline in new business in North America with an overall increase of commissions and fees in the three other regions. As we discussed in our previous earnings call, the implementation of our new organizational structure and restructuring impeded our market focus at the end of last year. We're still on track to generate growth as the year progresses and have already seen progress in our new business efforts, with steady increases in our pipeline each month. Health and Benefits have a strong commission and fee growth as a result of increased service to large market clients in North America, implementation and expansion of our global benefit management for multi-national clients and strong client retention in new business outside North America. Notably, timing of renewals in France and Spain created some softness in Western Europe for the quarter, though the year-to-date growth was nearly double-digit. Technology and Administration Solutions or TAS continue to produce strong results globally as we on boarded new clients in Great Britain and Western Europe and provided additional support to existing clients with respect to the UK legislative changes I mentioned earlier. As a side note, HCB revenues included a $5 million settlement related to the departure of Health and Benefits Brokerage teams. As you may recall, the company recognizes brokerage team settlements as revenues, which are included in adjusted earnings. We continue to have a positive outlook for the HCB business in 2017. Now, turning to Corporate Risk and Broking or CRB. Constant currency and organic commissions and fees were up 1% as compared to the prior year. For the first half of the year, CRB grew 2%. Commissions and fees growth was led by Great Britain, with wins in transportation, financial lines and natural resources. Western Europe up had solid growth, primarily led by Ireland and Iberia. Additionally, international experienced solid growth in Asia and Latin America, but experienced some softness related to the accelerated timing of policy placements and renewals in the first quarter due to regulatory changes. Commissions and fees declined in North America as a result of several large, onetime projects booked in 2016 as well as unfavorable rate and risk exposure changes. New business levels continued to grow as expected, and client retention stayed strong. We continue to be optimistic about the momentum in our CRB business going forward as we expected North American revenues to build in the second half of the year. Now to Investment, Risk & Reinsurance. Constant currency and organic commissions and fees increased 3% as compared to the prior year quarter. As a reminder, the Reinsurance line of business represents premiums based reinsurance only. The facultative reinsurance results are captured in the CRB segment. Reinsurance commissions and fees growth was a result of strong new business in international and favorable timing in specialty and in North America. Wholesale was soft in the second quarter due to the timing of renewals booked in the first quarter, which had been booked in the second quarter in the prior year. For the first half of 2017, wholesale commissions and fees grew by 4%. Risk Consulting and Software or RCS also experienced strong growth as a result of greater demand for project work in EMEA and software sales. Investment commissions and fees increased as a result of new delegated investment clients and increased performance fees. Max Matthiessen delivered strong growth due to higher performance fees as a result of new business and a more robust European equity market. As a reminder, we received a onetime $41 million settlement for the fine arts and jewelry business in the second quarter of 2016. As expected, we had a decline in total segment revenues due to this large onetime event. This also enhanced the second quarter 2016 segment margin by 8 percentage points. We continue to feel very positive about the momentum of the IRR business for 2017. And lastly, Exchange Solutions. Commissions and fees increased by 15% from the prior year. Driven by increased enrollments, our retiree and access exchange revenue increased 14%, and the rest of the segment increased 17%. Increased membership and new clients drove the revenue increase in our active employee exchange. The Health and Welfare in North American Pension Outsourcing business continue to grow, primarily due to new clients and customized active exchange projects. As the active exchange market evolves, we’re seeing the work we do for our clients split between the exchange and the administration teams, as well as all our health and benefits lob. As large companies make the initial move to exchanges for health benefit delivery, they’re opting for a more customized approach. The benefits administration group is currently more effective at providing this customization, as our outsourcing clients have unique requirements. As we move towards the 2018 enrollment period, it will become increasingly difficult to separate active exchange revenues from administration revenues and H&B revenues as we see these three groups working in collaboration with each other. Our 2018 active sales pipeline continues to look strong in both the mid-market and large market. As we mentioned in our previous earnings call, we have 6 large clients with about 150,000 total lives that have committed for the 2018 enrollment period and 1 large client committed for the 2019 enrollment period. The mid-market sales season will not be finalized until early November. Our channel brokers are keeping pace with prior year sales. The retiree exchange enrollment process is changing somewhat for 2018. We're seeing enrollments more evenly spread throughout the year, with a slight bump in enrollments in the fall of 2017, and the sales season is continuing as some larger companies are contemplating off-cycle enrollments. We're also seeing an impact from the current health care debate, and yet there are some clients who have held off this year until there is more clarity. Now while ACA doesn't generally impact Medicare retirees, it has a significant impact on the pre-65 retirees, and many companies are looking for a coordinated solution for both groups. We continue to be optimistic about the long-term growth of this business. So I'm excited to see the progress we've made in building Willis Towers Watson, not only evidenced by our first half results, but with the commitment of our colleagues as well. We recently received the results of our employee engagement survey, and I was most impressed with a couple of factors. First, the response rate was higher than we'd anticipated. This, alone, highlights to me that we have strong colleague engagement across the globe. Second, we scored very well in the areas that are key to our long-term success, such as positive responses relating to colleagues who are proud to be part of Willis Towers Watson, strong alignment to our values, colleagues who believe in our commitment to inclusion, having an environment where we value differences and colleagues who feel supported by their managers. We've also identified areas that need more focus as we work through our company's evolution and integration, but we now have a clear roadmap to move forward. I'm extremely proud of our colleagues, all 42,000, who've been instrumental in creating Willis Towers Watson. We've been given a unique opportunity to build an organization which reflects our values and a strong client commitment and also provides distinctive, integrated market-leading solution. The changes we have experienced in the last 18 months have been significant. I believe the financial results for the first half of this year reflect the engagement and commitment of our colleagues. As we move forward through the integration process, we can now shift greater focus to the market and build on the fundamentals of a merger strategy, which we believe will create more value for our clients, colleagues and shareholders. Based on what we've accomplished in the first 18 months, I'm excited as I look forward to the progress we can make together in the next 18 months. On a bittersweet note, this may be Roger's last conference call. And I say, maybe his last call, as Roger has been very gracious to remain flexible to ensure a smooth transition with a new CFO. Roger joined Watson Wyatt, a $2 billion company, just before the merger of equals that created Towers Watson. He played a key role in shaping that business and in enhancing the financial profile of the company. There were a host of acquisitions and mergers along the way. Perhaps, one of the most significant acquisitions, Extend Health, brought us the advent of the exchange business. Then, about 2 years ago, Roger was asked to take on the challenge of yet another merger of equals with the creation of Willis Towers Watson. As Roger retires from Willis Towers Watson, he leaves behind a $20 billion organization. We've experienced a great deal of change in Roger's tenure as CFO, but some things have remained rocksteady, such as Roger's pragmatic counsel and his desire to win. I want to thank Roger for his many contributions, guidance and his partnership over the last several years and hope that he and Robin have a long, healthy and rewarding retirement. Now I'll turn the call over to Roger.